Skip to main content
logo
Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
52.83
-0.01 (-0.02%)
At close: Apr 23, 2026, 4:00 PM EDT
52.88
+0.05 (0.09%)
After-hours: Apr 23, 2026, 6:53 PM EDT

Terns Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
6,1004,538483419547179
Market Cap Growth
3308.39%840.15%15.17%-23.37%206.12%-
Enterprise Value
5,0823,519125.44155.66264.3312.83
Last Close Price
52.8340.405.546.4910.187.07
PE Ratio
--39.22-4.95-5.11-6.10-3.20
PS Ratio
-----178.65
PB Ratio
5.904.511.401.641.971.11
P/TBV Ratio
4.893.741.271.811.331.00
P/FCF Ratio
--55.22-6.89-6.21-11.07-4.24
P/OCF Ratio
--55.22-6.89-6.22-11.14-4.27
EV/Sales Ratio
-----12.83
EV/EBITDA Ratio
--32.10-1.24-1.53-4.33-0.26
EV/EBIT Ratio
--31.96-1.23-1.52-4.26-0.26
EV/FCF Ratio
--42.83-1.79-2.31-5.35-0.30
Debt / Equity Ratio
0.000.000.0000.000.00
Debt / EBITDA Ratio
-0.01-0.01-0.01-0.01-0.020.00
Debt / FCF Ratio
-0.01-0.01-0.02-0.01-0.020.00
Net Debt / Equity Ratio
-1.01-1.01-1.03-1.03-1.02-1.03
Net Debt / EBITDA Ratio
9.299.293.532.594.623.36
Net Debt / FCF Ratio
12.3912.395.093.905.713.93
Asset Turnover
-00000.01
Quick Ratio
62.0962.0922.8922.0633.4324.34
Current Ratio
62.4162.4123.1422.3933.6824.48
Return on Equity (ROE)
-14.23%-14.23%-29.56%-33.89%-27.60%-43.83%
Return on Assets (ROA)
-15.95%-15.95%-32.31%-37.02%-27.42%-38.69%
Return on Invested Capital (ROIC)
1148.23%1148.23%1299.79%2024.42%1446.60%-3646.05%
Return on Capital Employed (ROCE)
-16.23%-16.23%-33.68%-38.33%-28.21%-43.22%
Earnings Yield
-1.58%-2.55%-20.22%-19.57%-16.40%-31.26%
FCF Yield
-1.35%-1.81%-14.51%-16.09%-9.03%-23.60%
Buyback Yield / Dilution
-17.18%-17.18%-11.58%-97.76%-58.69%-7862.46%
Total Shareholder Return
-17.18%-17.18%-11.58%-97.76%-58.69%-7862.46%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q